Challenges in Infective Endocarditis
-
Register
- User - $30
Infective endocarditis (IE) is defined by a focus on infection within the heart and is a feared disease by clinicians as the challenges posed by IE are significant. IE frequency occurs in patients without heart disease, those with devices and in intravenous drug users. With the rising increase in this disease, it is imperative that clinicals are able to recognize and promptly treat these individuals. Learn about risks for IE, diagnosis and treatment, and the lasts relevant guidelines.
Credits: 1.0 Contact Hours; 0.50 are Pharmacology
Expiration Date: December 31st, 2025
$30
LEARNING OBJECTIVES
After taking part in this educational activity, participants should be better able to:
-Identify risk factors for endocarditis
-Discuss appropriate measures to diagnosis endocarditis
-Discuss treatment measures for endocarditis
Kristine Scordo PhD, RN, ACNP-BC, FAANP
Professor and Director
Wright State University
Dr. Kristine Scordo has over 35 years as an APRN including former founder and director of the acute care NP program in Dayton, OH. She has lectured extensively at international, national and regional conferences on topics in infectious diseases and adult cardiology, establishing a critical care fellowship in Hong Kong. She was involved in developing the competencies for graduate fellowships and continues to be a CCNE site visit accrediting colleges and fellowships. She and has been awarded multiple grant funding and has multiple publications and continues to practice at TriHealth in Cincinnati, Ohio.
CE INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Dashboard' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.0 contact hours, of which 0.50 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Accreditation Statement
Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
DISCLOSURES
Faculty
Contributing faculty, Kristine Scordo, PhD, APRN, ACNP-BC, FAANP has disclosed no financial relationship.
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.